Given the beneficial effects of several precursors and inhibitors summarized above, these strategies may be promising for finding a therapeutic strategy for AD, either as lead molecules or in combination approaches with other classes of molecules or drugs, with several studies having been launched at the clinical level
in some animal models, the cellular phenotypes of CNI appeared to translate to a reduced propensity to arrhythmia (103, 105, 106), but not in other models (101, 102)
While this new study finds a more modest increase in NAION incidence than was reported in earlier studies, researchers continue to advocate for greater vigilance among healthcare providers prescribing GLP-1 receptor agonists like semaglutide, which is marketed under the brand names Ozempic, Wegovy, and Rybelsus
This greatly improves their life quality